Vectivbio Holding Ag Stock Fundamentals
| VECTDelisted Stock | USD 16.85 0.00 0.00% |
VectivBio Holding AG fundamentals help investors to digest information that contributes to VectivBio Holding's financial success or failures. It also enables traders to predict the movement of VectivBio Stock. The fundamental analysis module provides a way to measure VectivBio Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VectivBio Holding stock.
VectivBio |
VectivBio Holding AG Company Return On Equity Analysis
VectivBio Holding's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current VectivBio Holding Return On Equity | -0.57 |
Most of VectivBio Holding's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VectivBio Holding AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, VectivBio Holding AG has a Return On Equity of -0.5692. This is 97.63% lower than that of the Biotechnology sector and 98.44% lower than that of the Health Care industry. The return on equity for all United States stocks is 83.61% higher than that of the company.
VectivBio Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VectivBio Holding's current stock value. Our valuation model uses many indicators to compare VectivBio Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VectivBio Holding competition to find correlations between indicators driving VectivBio Holding's intrinsic value. More Info.VectivBio Holding AG is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value VectivBio Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.VectivBio Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VectivBio Holding's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of VectivBio Holding could also be used in its relative valuation, which is a method of valuing VectivBio Holding by comparing valuation metrics of similar companies.VectivBio Holding is currently under evaluation in return on equity category among its peers.
VectivBio Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (2.95) % | |||
| Current Valuation | 846.2 M | |||
| Shares Outstanding | 62.81 M | |||
| Shares Owned By Insiders | 4.50 % | |||
| Shares Owned By Institutions | 83.80 % | |||
| Number Of Shares Shorted | 77.6 K | |||
| Price To Book | 3.62 X | |||
| Price To Sales | 21.08 X | |||
| Revenue | 27.34 M | |||
| Gross Profit | 27.34 M | |||
| EBITDA | (79.85 M) | |||
| Net Income | (93.73 M) | |||
| Cash And Equivalents | 142.14 M | |||
| Cash Per Share | 3.09 X | |||
| Total Debt | 10.46 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 4.69 X | |||
| Book Value Per Share | 3.40 X | |||
| Cash Flow From Operations | (56.26 M) | |||
| Short Ratio | 0.04 X | |||
| Earnings Per Share | (2.10) X | |||
| Target Price | 18.33 | |||
| Number Of Employees | 10 | |||
| Beta | 0.1 | |||
| Market Capitalization | 1.06 B | |||
| Total Asset | 252.6 M | |||
| Retained Earnings | (207.76 M) | |||
| Working Capital | 201.47 M | |||
| Z Score | 59.56 | |||
| Net Asset | 252.6 M |
About VectivBio Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VectivBio Holding AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VectivBio Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VectivBio Holding AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. VectivBio Holding is traded on NASDAQ Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in VectivBio Stock
If you are still planning to invest in VectivBio Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VectivBio Holding's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |